OR WAIT null SECS
April 01, 2016
At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.
March 29, 2016
Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.
March 02, 2016
Asking the right questions is crucial to establishing a biopharmaceutical facility design.
The pharma company revealed in a fourth quarter call that it will improve its cell-culture capabilities by focusing on the use of naïve, highly proliferative cells to manufacture its CAR-T drug candidate.
February 18, 2016
The course, intended for healthcare professionals, provides an overview of biosimilar products and FDA’s biosimilar product development programs.
February 09, 2016
There are no clinically meaningful differences between Celltrion’s CT-P13 and Remicade, according to an FDA briefing released ahead of the formal panel meeting.
February 04, 2016
Although switching has occurred in European markets for some biosimilars, most biosimilar manufacturers will focus on securing new users, according to Merck.
February 02, 2016
Scale-down modeling is instrumental in supporting the development of downstream biopharma manufacturing processes.